Concord Drugs consolidated net profit declines 4.35% in the December 2025 quarter
Sales rise 57.13% to Rs 16.97 crore
Net profit of Concord Drugs declined 4.35% to Rs 0.22 crore in the quarter ended December 2025 as against Rs 0.23 crore during the previous quarter ended December 2024. Sales rose 57.13% to Rs 16.97 crore in the quarter ended December 2025 as against Rs 10.80 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales16.9710.80 57 OPM %5.5412.87 -PBDT0.600.90 -33 PBT0.300.53 -43 NP0.220.23 -4Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content